1 The effect of imipramine in concentrations between 0.01 gM and 50 gM has been studied on bovine Purkinje fibres and ventricular muscle transmembrane potentials. 2 In electrically stimulated fibres, imipramine had no effect on the resting membrane potential, but decreased the action potential amplitude, overshoot and maximum rate of depolarization ( 3 In Purkinje fibres, imipramine also decreased the conduction velocity and shifted the membrane responsiveness and recovery time curves downward and to the right. 4 In both Purkinje fibres and ventricular muscle, imipramine decreased the amplitude of phase 2 and prolonged phase 3. In Purkinje fibres, imipramine did not alter the action potential duration (APD) but prolonged the effective refractory period (ERP). In ventricular muscle, at concentrations higher than 1 gIM imipramine shortened both the APD and the ERP and made the ERP long as compared to APD. 5 Imipramine decreased the slope of phase 4 diastolic depolarization in spontaneously beating Purkinje fibres. 6 These properties of imipramine are quite similar to those of quinidine or procainamide (class 1 antiarrhythmics). The mechanisms responsible for the cardiac effect of imipramine are discussed.
Introduction Methods
Tricyclic antidepressants have powerful effects on the cardiovascular system. Soon after the introduction of imipramine, Kristiansen (1961) reported minor ST-T changes in the electrocardiogram and hypotension of treated patients. Since then, various changes in the ECG-pattern, including prolongation of the PQ and QT intervals, ST and T-wave abnormalities and widening of the QRS complex, have been described both after overdosage or during chronic therapy (Jefferson, 1975) . Most clinical reports also claim that imipramine may produce ventricular arrhythmias in patients with or without antecedent heart disease (Vohra, Burrows & Sloman, 1975) . On the other hand, some experimental (Sigg, Osborn & Korol, 1963; Fekete & Borsy, 1964) and clinical reports (Bigger, Giardina, Kantor & Glassman, 1977) indicate that imipramine could act as an antiarrhythmic agent. Recent studies in guinea-pig papillary muscles (Garcia de Jal6n, Rodriguez & Tamargo, 1978) have demonstrated that it decreased the maximum rate of depolarization, shortened the action potential duration and suppressed the calcium-mediated action potentials. However, little information is available on the effects of imipramine on Purkinje fibres. Figure 2a . Before treatment the control Purkinje V was slightly depressed at the two most rapid frequencies of stimulation. Imipramine (1 AM, 5 JiM and 10 pM) significantly (P < 0.01) reduced the peak I', at any given frequency, but the decrease was less pronounced the lower the frequencies. A similar rate-dependence of Vmax was observed when instead of constant rates of stimulation, premature action potentials were elicited at different intervals after the end of the preceding basic action potential. When the fibres were exposed to the highest concentration of imipramine (50 gM) there was a marked decrease in V accompanied by a depression of the rapid component of the upstroke. In fact, shortly after exposure to this concentration, the upstroke consisted of two phases, a first phase markedly reduce in rate and amplitude, followed by a slow rising secondary depolarization up to the normal plateau level (Figure 1 ).
At 50 pM all fibres became unexcitable in 10 to 15 min. The voltage-time course of the action potential was also altered by imipramine, shortening the APD50. This shortening was mainly due to a depression in-the amplitude of phase 2 and to an altered slope of the plateau which was shifted to more negative potentials. As a consequence, the onset of phase 3 occurred earlier and its duration progressively increased. However, the terminal portion of phase 3 repolarization was prolonged so that even though there was proportionately faster repolarization during earlier phases, the APD90 did not differ significantly from controls at any concentration (Table 1) . The voltage-time course of repolarization of Purkinje fibres and a typical experiment is illustrated in Figure 1 .
Ventricular muscle. The effects of impramine were also studied in ventricular muscle. Table 2 izes the data and Figure 3 shows a typical experiment. Imipramine at concentrations higher than 5 JM caused a progressive decrease in action potential amplitude, overshoot and V,, but no significant changes were observed at these concentrations in membrane resting potential. As in Purkinje fibres, imipramine decreased the V,, in ventricular fibres at all stimulation frequencies, but the decrease was greater at rapid than at low frequencies (Figure 2b ). At these concentrations (10 JM and 50 JM), imipramine significantly shortened the APD50 and APD90 (P < 0.01 amplitude, was studied in five experiments. Imipramine, 1 JM and 10 pM, depressed the recovery time, shifting the curve downwards and to the right ( Figure 5 ). As can be observed in this figure, at these concentrations imipramine also prolonged the ERP in Purkinje fibres and reduced the V,,,., of the first premature response.
Condluction velocit i
The decrease in action potential amplitude and Jmax resulted in a fall of the conduction velocity. Conduction time was measured between two intracellular microelectrodes located at either end of a free-running Purkinje fibre. The action potential recorded from the two sites were displayed at fast sweep speed allowing the measurement of conduction time between the two action potential upstrokes. The distance between the two microelectrodes was estimated through the micrometer eye piece of the microscope. In five experiments exposure to imipramine (I pM, 5 pM and 10 pM) for 30 min, decreased the control conduction velocity (2.8 + 0.6 m/s, mean + s.e.) to 2.2 + 0.4 m/s, 1.8 + 0.3 m/s and 1.4 + 0.2 m/s, respectively (P < 0.01). These effects were still more pronounced at higher frequencies of stimulation. In Purkinjemuscle preparations, a partial block in orthodromic direction was observed after perfusion with imipramine, 10 JIM. 
Effective refractori' period
The ERP, defined as the period in which no propagated action potentials can be obtained, was determined in Purkinje fibres and in ventricular muscle in eight experiments. Preparations were driven at a constant rate and premature test-stimuli were delivered at various intervals every eighth basic drive stimulus. In Figure 6 the changes induced in APD, so that the ratio of the change in ERP to the change in APD was always greater than one.
Spontaneous activity
The effects of imipramine were examined in seven spontaneously beating Purkinje fibres in which automaticity was elicited by reducing the external potassium concentration to 2.7 mm. A typical experiment is shown in Figure 7a . In all preparations imipramine (5 gM) significantly reduced the slope of phase 4 diastolic depolarization and slowed the spontaneous rate. This effect was largely due to a selective decrease in the rate of diastolic depolarization during late diastole, whereas it affected phase 4 only slightly during early diastole. At a concentration of 10 gM, imipramine suppressed the spontaneous activity with the membrane potential arrested at a depolarized level (Figure 7a, right) . Similar results were obtained in four other experiments in which automatic activity was induced in ventricular muscle bathed in Tyrode 
Discussion
Transmembrane potentials of Purkinje fibres and ventricular muscle were studied during perfusion with imipramine. The concentrations used in this study, ranging from 0.0028 pg/ml to 14 1.g/ml, comprised both therapeutic plasma levels (95 to 1050 ng/ml) and those found after over-dosage (up to 2190 ng/ml; Glassman & Perel, 1973) . However, it is very difficult to relate in vivo plasma concentrations to the concentrations of the drug perfusing isolated cardiac tissues, particularly when a 10 to 20 fold variation in tricyclic plasma levels has been found among patients taking the same dose (Asberg, 1973; Glassman & Perel, 1973) . On the other hand, it is known that some therapeutic or toxic effects of imipramine appeared only after repeated administration of the drug for days or weeks.
Imipramine decreased action potential amplitude, overshoot and V,,,,.x in the absence of any change in resting membrane potential, depressed membrane responsiveness and slowed ventricular conduction. These effects were similar to those described for antiarrhythmic drugs having local anaesthetic properties on nerve, i.e. quinidine or procainamide, and have been attributed to an interference with an increase in Na conductance (gNa) and as a consequence, with the activation of the fast inward Na+ current during phase 0 depolarization (Weidmann, 1955b; Vaughan Williams, 1970) . In fact, imipramine appears to be 2.7 and 6.7 times more potent as a local anaesthetic than -lidocaine and mepiramine, respectively, and 4 times as active as tetracaine on desheathed frog nerve (Guerrero & Molgo, 1974) . Recently, in voltage-clamp experiments, imipramine (I to 50 pM) was shown to suppress the gNa in the Myxicola giant axon without having any effect on resting membrane potential (Schauf, Davis & Kesler, 1975 (Hoffman & Cranefield, 1960 (Weidmann, 1955a (Johnson & McKinnon, 1957) , as well as for phenothiazines (Arita & Surawicz, 1973) and desipramine (Tamargo, Rodriguez & Garcia de Jalon, 1979 (Giebish & Weidmann, 1971 (Cranefield, Wit & Hoffman, 1973) . Suppression of automaticity has been considered to be one of the essential electrophysiological properties of antiarrhythmic drugs. Imipramine could suppress automatic rhythms originating in the His-Purkinje system directly, since it greatly decreased the slope of phase 4 diastolic depolarization in spontaneously beating Purkinje fibres; moreover, it also depressed the Ba-induced atuomaticity elicited in ventricular muscle. Weidmann (1955b) suggested that the principal mode of action of quinidine and procainamide is a prolongation of the ERP of Purkinje fibres out of proportion to any increase in APD. Since then, an increase of the ratio ERP over APD has been considered as an important requisite for antiarrhythmic effectiveness. Imipramine increased the ratio in both Purkinje fibres and ventricular muscle. Prolongation of the ERP in absolute value was observed in Purkinje fibres, while in ventricular muscle ERP was prolonged only in relation to a shorter action potential. Imipramine would thus cause early recirculating impulses to be blocked, and the rate of depolarization of the earliest premature beat will occur at more negative membrane potentials, thereby enhancing intraventricular conduction and possibly eliminating reentrant beats by depressed conduction. Imipramine also decreased intraventricular conduction. A sufficient reduction in conduction velocity could interrupt ventricular re-entry by another mechanism, i.e. by transformation of unidirectional into bidirectional conduction block.
Most of the observed effects of imipramine on ventricular action potentials that already have been described are similar to the effects of compounds classified as membrane stabilizers, class 1 antiarrhythmics according to the classification of Vaughan Williams (1970) . However, this study reveals that imipramine also decreased conduction velocity, increased the discrepancy between the APD in the Purkinje fibres and in the ventricular muscle, and altered the relation between ERPs in the Purkinje and in the ventricular fibres. These effects decreased ventricular electrical stability by increasing the difference in dispersion of ventricular refractoriness and increased the nonuniform recovery of excitability between Purkinje fibres and ventricular muscle. On the other hand, depression of conduction may lead to adverse effects such as decremental conduction or block in previously normal cardiac tissues. As a consequence, imipramine increased ventricular inhomogeneity and enhanced the tendency to re-entry phenomena resulting in ventricular premature beats -and ventricular tachycardia (proarrhythmic effects of imipramine). The intraventricular conduction disturbances observed in patients treated with imipramine may be attributed to a combination of a decrease in membrane responsiveness and to the induction of timedependent changes in the V,,,,X of Purkinje and ventricular fibres. Reduction of V and conduction velocity could also explain the widening of the QRS complex, and since the changes were more pronounced at rapid heart frequencies they could explain the ventricular aberrancy accompanying tachycardia in treated patients. Slowing of the terminal portion of repolarization in Purkinje fibres may be responsible for the decrease in T wave amplitude and possibly for the ST-T abnormalities and for the prolongation of the QTc interval observed in these patients.
